Literature DB >> 15547671

Biological fate of tissue-engineered porcine valvular conduits xenotransplanted in the sheep thoracic aorta.

Maria Teresa Conconi1, Francesco Rocco, Raffaella Spinazzi, Mara Tommasini, Carlo Valfrè, Roberto Busetto, Elvio Polesel, Giovanna Albertin, Angelo Dei Tos, Ilaria Iacopetti, Attilio Cecchetto, Claudio Zussa, Mauro Grigioni, Pier Paolo Parnigotto, Gastone Giovanni Nussdorfer.   

Abstract

The ideal prosthesis to replace the diseased human aortic valve is not yet available. We have previously shown that porcine acellular aortic-valve conduits, obtained by detergent-enzymatic method, display hemodynamic performances similar to those of their native counterparts. Hence, it seemed worthwhile to ascertain whether these tissue-engineered prostheses can be successfully xenotransplanted. Porcine acellular conduits, which immunocytochemistry demonstrated to lack MHC class I and II antigens, were implanted in the thoracic aorta of 9 sheep. Two animals died just after surgery, and the other 7 sheep were sacrificed 1 or 5 months after transplantation. A rather favorable outcome of the implant was observed in 4 sheep. In these animals, aortic valves remained pliable and coaptive, and the luminal surface of the conduits was endothelized just after one month from surgery. An intense inflammatory response was present at 1 month, and, although attennuated, it persisted for 5 months, located mainly between the tunica intima and media and at the border of the implant. Vimentin-positive and smooth muscle actin-positive myofibroblasts proliferated within tunica media and adventitia, and an obvious thickening of the tunica intima was also observed. Small vessels were seen in the adventitia, and elastic fibers were well-preserved in both the aorta wall and valve leaflets. In the cases of unfavorable outcome (3 of 7 survived sheep), implants were detached from the aorta recipient and surrounded by a connective mass that almost completely obstructed their lumen. These masses were composed of a fibromyxoid background where proliferating cells, resembling those occurring in human reactive myofibroblastic lesions (proliferative fascitis), were embedded. Collectively, these rather disappointing findings indicate that acellular valve conduits, obtained by the detergent-enzymatic method, are presently not suitable for clinical applications because of the persistent inflammatory response, which conceivably triggers overgrowth mechanisms that lead to implant failure.

Entities:  

Mesh:

Year:  2004        PMID: 15547671

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  2 in total

1.  In vivo evaluation of an in-body, tissue-engineered, completely autologous valved conduit (biovalve type VI) as an aortic valve in a goat model.

Authors:  Yoshiaki Takewa; Masashi Yamanami; Yuichiro Kishimoto; Mamoru Arakawa; Keiichi Kanda; Yuichi Matsui; Tomonori Oie; Hatsue Ishibashi-Ueda; Tsutomu Tajikawa; Kenkichi Ohba; Hitoshi Yaku; Yoshiyuki Taenaka; Eisuke Tatsumi; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2012-12-20       Impact factor: 1.731

2.  Blood vessel-derived acellular matrix for vascular graft application.

Authors:  Luigi Dall'Olmo; Ilenia Zanusso; Rosa Di Liddo; Tatiana Chioato; Thomas Bertalot; Enrica Guidi; Maria Teresa Conconi
Journal:  Biomed Res Int       Date:  2014-07-16       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.